Ignite Creation Date:
2025-12-26 @ 12:16 PM
Ignite Modification Date:
2025-12-31 @ 9:58 PM
Study NCT ID:
NCT00169000
Status:
COMPLETED
Last Update Posted:
2009-08-06
First Post:
2005-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
D-0139
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gary N. Schwartz
Old Organization:
Dartmouth-Hitchcock Medical Center
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |